Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at FoxHollow Technologies.
Report 1: FoxHollow Technologies (FOXH), which manufactures and markets minimally invasive devices for the treatment of peripheral artery disease, recently provided an update on the company's strategic direction.
The company also announced that preliminary unaudited revenue for the fourth quarter of 2006 was approximately $44.7 million, a 7% increase over revenue of $41.9 million in the fourth quarter of 2005. Revenue for the fourth quarter of 2006...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.